Screener / SEC EDGAR /CIK 0000882796 /10-K filed Feb 26, 2026, compared with Feb 25, 2025 /Numbers from the XBRL of the 10-Ks
Nasdaq Health care · Biotechnology

Biocryst Pharmaceuticals Inc BCRX

Compare with peers Embed
Filings with the SEC since Mar 10, 2016

992 filings, 2 in the last 30 days

SEC filing index

What the 8-Ks said

2 events in the last 3 years: the officer, auditor, restatement, cyber, restructuring, listing, impairment and debt items. One line each, the filing's own words.

CEO, CFO, COO or CAO: 0 (item 5.02)Auditor change: 0 (item 4.01)Not to be relied on: 0 (item 4.02)Cybersecurity: 0 (item 1.05)Restructuring: 2 (item 2.05)Listing notice: 0 (item 3.01)Impairment: 0 (item 2.06)Debt trigger: 0 (item 2.04)

From the SEC filing index and the text of each 8-K. A line appears only when the 8-K names one of these items; for item 5.02 only a move of the CEO, CFO, COO or chief accounting officer. Older 8-Ks may have no text downloaded, so they show no quote.

Late filings, 8-K notices and going concern

None found in the last 2 years

All checks
  • Late filing notices (NT 10-K, NT 10-Q)
    No notice in the last 2 years.
  • 8-K notices: listing, impairment, debt trigger
    No item 3.01, 2.06 or 2.04 in the last 2 years.
  • Going-concern language in the 10-K
    No statement of substantial doubt in the latest 10-K.

Facts to read in the filing, not a verdict: many companies with one of these carry on normally, and a company with neither can still have problems.

Every filing on one line

Each mark is a filing or an event in one; the bigger square is a 10-K. Hover for what it is, click to open it.

Annual report (10-K)Quarterly report (10-Q)Current report (8-K)Auditor changeCEO, CFO, COO or CAO changeRestatementLate filing noticeInsider purchaseCluster buy (3+ insiders)SEC comment letterShare offering (S-3, 424B)Planned insider sale (Form 144, 10b5-1)
All 61 events

From the SEC filing index. Insider purchases go back 180 days (the Form 4s downloaded).

Every filing

Newest first, by kind · each form links to sec.gov

FiledFormWhat it is
Nov 4, 2026 10-Q Quarterly report
Nov 4, 2026 8-K Quarterly results, Regulation FD disclosure
Sep 2, 2026 4 Insider trade
Sep 2, 2026 4 Insider trade
Sep 2, 2026 4 Insider trade
Sep 2, 2026 4 Insider trade
Sep 2, 2026 4 Insider trade
Aug 14, 2026 SCHEDULE 13G/A 5%+ owner (passive), amended
Aug 5, 2026 10-Q Quarterly report
Aug 5, 2026 S-8 Shares registered for employee plans
Aug 5, 2026 8-K Quarterly results, Regulation FD disclosure
Aug 4, 2026 8-K/A Restructuring or exit costs
Jun 29, 2026 8-K Restructuring or exit costs, Regulation FD disclosure
Jun 15, 2026 4 Insider trade
Jun 15, 2026 4 Insider trade
Jun 15, 2026 4 Insider trade
Jun 15, 2026 4 Insider trade
Jun 15, 2026 4 Insider trade
Jun 15, 2026 4 Insider trade
Jun 15, 2026 4 Insider trade
Jun 15, 2026 4 Insider trade
Jun 15, 2026 4 Insider trade
Jun 12, 2026 8-K Director or officer change, Shareholder vote results
Jun 2, 2026 4 Insider trade
Jun 2, 2026 4 Insider trade
Jun 2, 2026 4 Insider trade
Jun 2, 2026 4 Insider trade
Jun 2, 2026 4 Insider trade
May 19, 2026 4 Insider trade
May 18, 2026 144 Notice of planned insider sale
May 15, 2026 4 Insider trade
May 13, 2026 144 Notice of planned insider sale
May 6, 2026 10-Q Quarterly report
May 6, 2026 8-K Quarterly results, Regulation FD disclosure
May 4, 2026 8-K Regulation FD disclosure
Apr 29, 2026 SCHEDULE 13G 5%+ owner (passive)
Apr 23, 2026 DEF 14A Proxy statement
Apr 23, 2026 ARS Annual report to shareholders
Apr 23, 2026 DEFA14A Extra proxy material
Apr 7, 2026 3 New insider
Apr 7, 2026 4 Insider trade
Mar 26, 2026 SCHEDULE 13G/A 5%+ owner (passive), amended
Mar 24, 2026 4 Insider trade
Mar 20, 2026 144 Notice of planned insider sale
Mar 18, 2026 4 Insider trade
Mar 16, 2026 144 Notice of planned insider sale
Mar 3, 2026 4 Insider trade
Mar 3, 2026 4 Insider trade
Mar 3, 2026 4 Insider trade
Mar 3, 2026 4 Insider trade
Mar 3, 2026 4 Insider trade
Mar 2, 2026 144 Notice of planned insider sale
Feb 26, 2026 10-K Annual report
Feb 26, 2026 8-K Quarterly results, Regulation FD disclosure
Feb 12, 2026 SCHEDULE 13G/A 5%+ owner (passive), amended
Jan 27, 2026 3 New insider
Jan 27, 2026 4 Insider trade
Jan 23, 2026 8-K/A Director or officer change
Jan 23, 2026 8-K Material agreement signed, Acquisition or sale of assets completed, New debt or obligation, Regulation FD disclosure
Jan 12, 2026 8-K Quarterly results, Regulation FD disclosure, Other events
Jan 9, 2026 3 New insider
Jan 9, 2026 8-K Regulation FD disclosure
Dec 23, 2025 4 Insider trade
Dec 23, 2025 4 Insider trade
Dec 23, 2025 4 Insider trade
Dec 22, 2025 144 Notice of planned insider sale
Dec 19, 2025 4 Insider trade
Dec 19, 2025 4 Insider trade
Dec 19, 2025 4 Insider trade
Dec 19, 2025 4 Insider trade
Dec 18, 2025 EFFECT
Dec 18, 2025 424B3
Dec 16, 2025 CORRESP Company's reply to the SEC
Dec 16, 2025 4 Insider trade
Dec 16, 2025 4 Insider trade
Dec 16, 2025 4 Insider trade
Dec 15, 2025 144 Notice of planned insider sale
Dec 15, 2025 S-4/A
Dec 12, 2025 8-K Other events
Dec 11, 2025 8-K Director or officer change
Dec 3, 2025 144 Notice of planned insider sale
Dec 3, 2025 425
Dec 3, 2025 8-K Other events
Dec 3, 2025 4 Insider trade
Dec 2, 2025 144 Notice of planned insider sale
Dec 2, 2025 4 Insider trade
Dec 2, 2025 4 Insider trade
Dec 2, 2025 4 Insider trade
Dec 1, 2025 144 Notice of planned insider sale
Nov 25, 2025 144 Notice of planned insider sale
Nov 21, 2025 144 Notice of planned insider sale
Nov 20, 2025 S-4
Nov 17, 2025 4 Insider trade
Nov 13, 2025 144 Notice of planned insider sale
Nov 12, 2025 SCHEDULE 13G 5%+ owner (passive)
Nov 4, 2025 10-Q Quarterly report
Nov 3, 2025 8-K Quarterly results, Regulation FD disclosure
Oct 14, 2025 425
Oct 14, 2025 425
Oct 14, 2025 425
Show the other 75 filings on this page

Press releases with quarterly results are attached to the 8-Ks marked "Quarterly results"; read them on Earnings releases.

Sources

SEC's filing index (data.sec.gov submissions). Each form links to the document on sec.gov.

Also

Earnings releases: the text of each quarter's results release. Statements by period: the income statement, balance sheet or cash flow of the last filings side by side.

Work with it

Excel workbook · CSV. Google Sheet that stays up to date: paste =IMPORTDATA("https://tickdelta.com/company/BCRX/export.csv") into a cell.

Next:Earnings releases
Esc

Type a ticker such as AAPL, a name, an investor such as Buffett, or a topic such as tariffs. ↑ ↓ to move, Enter to open.